Current ebola vaccinesMucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routesMimotope vaccination--from allergy to cancerGene therapy for mucopolysaccharidosisThe status of gene therapy for brain tumorsCell-based therapy for ischemic strokeAdvances in the formation, use and understanding of multi-cellular spheroidsBlinatumomab: enlisting serial killer T-cells in the war against hematologic malignanciesCombinatorial RNA-based gene therapy for the treatment of HIV/AIDSStem cell therapy for chronic heart failure: an updated appraisalInduction of cellular and molecular immunomodulatory pathways by vitamin A and flavonoidsNew era of biologic therapeutics in atopic dermatitisMelanocyte stem cells as potential therapeutics in skin disordersUsing gene therapy to manipulate the immune system in the fight against B-cell leukemiasCardiovascular gene therapy for myocardial infarctionContemporary use of bevacizumab in ovarian cancerBiomaterials and stem cells for tissue engineeringThymosin α1 inserts N terminus into model membranes assuming a helical conformationThe use of the NIS reporter gene for optimizing oncolytic virotherapyAdvances in salivary gland gene therapy - oral and systemic implicationsEnhancing and targeting nucleic acid delivery by magnetic forceRole of abciximab in the treatment of coronary artery diseaseBecaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcersThe use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss9th Annual Meeting of the Regional Cancer Consortium for the Biological Therapy of Cancer. 16-18 February 2006, UPMC Herberman Conference Center, Pittsburgh, PA, USAThe therapeutic potential of ΦC31 integrase as a gene therapy systemOcrelizumab: a step forward in the evolution of B-cell therapyCDP-870 (certolizumab) in rheumatoid arthritisStem cell therapy for joint problems using the horse as a clinically relevant animal modelThe use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in orthopaedic applicationsModification of mammalian reoviruses for use as oncolytic agentsFeverfew: weeding out the root of leukaemiaExosomes for repair, regeneration and rejuvenationNatalizumab and the role of alpha 4-integrin antagonism in the treatment of multiple sclerosisThe potential of nestin-expressing hair follicle stem cells in regenerative medicineThe evolving role of catumaxomab in gastric cancerSTAT3 as a therapeutic target in head and neck cancerEnhancing and targeting nucleic acid delivery by magnetic forceAnticalins as an alternative to antibody technology.Production of adenovirus vectors and their use as a delivery system for influenza vaccines.
P1433
Q21534720-809685D7-E6C1-4E39-A56C-EDDB152C4F06Q22241377-2A2A1EF9-EB5C-45E0-AAF5-3F890D55DE4EQ24608624-B5A9253D-8FCD-48B9-B7D1-34A84114D5CCQ24631135-FD288748-AC69-4317-88C3-EDF372565AD2Q24651009-8C70B27D-EBD5-414E-884E-8F6341819795Q26827499-4E526E30-247E-4336-B212-3B21A1DA64FFQ26828808-038F5DCA-B586-4E97-BB3B-833AF86B4B2DQ26865838-4EE32A7F-D285-47F7-834F-925D174DF231Q26866145-FCEB6B1B-F44D-42FD-825B-2F0655808797Q26866170-AB119A06-D216-4E6E-9EB8-7865503F79AAQ26995750-A6579284-44E6-47D9-A15A-36990BC180B9Q27001941-8943C076-7921-4BDF-94FF-5FF8E8EAF7A8Q27008330-ED54486D-D002-46F3-92B8-E51C65A8AF01Q27011297-D3CF4346-E398-4AA3-98A7-CA24AF59E5AFQ27014770-851EB824-8098-41F9-BB38-29C3432BA7DCQ27023510-19A61A5A-BF4E-45EB-99B4-16E8E7D965BBQ27025631-12700A28-632B-4BAB-9DCB-31B51D692F68Q27697726-A3B19CCD-E3C5-4277-96B0-48F587E894E0Q28083534-F1212C3E-3FBB-470F-985D-2518D66ADCA9Q28084318-325976B7-367A-4FEB-A3C4-131D3F8B679AQ28189510-80C04D88-D9E4-4C73-BBD4-BD4B44B881DFQ28200177-92B3736F-13A5-4A9A-B5E0-490E1CCA2CB2Q28201897-334B4321-A11C-4E1C-B47B-D5E114259AF2Q28208335-E89DBCE2-220D-4B95-9CFE-0873D919774DQ28240743-866BB33D-8DAD-4D45-BD59-9233F42BB870Q28242655-98AF9A47-03F0-47CD-827D-6923939FCE64Q28245986-DC728070-2430-47EE-ACCB-D93B5D78D5F8Q28254498-8F59E7E1-2F88-46EF-AF5E-72975915E10CQ28254800-2797AA8D-C9D4-4C30-9FE0-9BC282193143Q28262713-5C6AEDE3-D093-4DAC-A941-932CB3D4292DQ28264900-64633726-2368-4B93-8D1F-2CBD8DCA40CDQ28268808-9B3D875D-193B-4B42-85CB-B2D85E8BC2AAQ28272609-7B044EC5-A684-41A1-8FF3-D2B3ECD606B6Q28277470-EFE827D8-A6DF-44C8-94DD-8992F4DBDA99Q28288877-53BB7E60-9479-4EEE-9353-EF48BBB1ED4CQ28290511-7605AD6B-D88F-4BDB-A1B7-AA81FF91ABE3Q28299368-723CCEE4-977C-4B3B-8BF3-A43184E58E5FQ29999620-22D5BC02-76E6-4225-8EAA-92BA927259FFQ30160091-853F71CB-AE23-45C8-9E03-F53F43E20023Q30226988-C6FDE71F-1F88-47D9-B36D-178C442B595B
P1433
description
Medical journal
@en
Medical journal
@en-gb
Medizinische Fachzeitschrift
@de
Revue médicale
@fr
revista científica
@es
rivista scientifica
@it
vědecký časopis
@cs
wetenschappelijk tijdschrift van Informa
@nl
वैज्ञानिक पत्रिका
@hi
name
Expert Opinion on Biological Therapy
@ast
Expert Opinion on Biological Therapy
@da
Expert Opinion on Biological Therapy
@de
Expert Opinion on Biological Therapy
@en
Expert Opinion on Biological Therapy
@en-ca
Expert Opinion on Biological Therapy
@en-gb
Expert Opinion on Biological Therapy
@es
Expert Opinion on Biological Therapy
@fi
Expert Opinion on Biological Therapy
@fr
Expert Opinion on Biological Therapy
@it
type
label
Expert Opinion on Biological Therapy
@ast
Expert Opinion on Biological Therapy
@da
Expert Opinion on Biological Therapy
@de
Expert Opinion on Biological Therapy
@en
Expert Opinion on Biological Therapy
@en-ca
Expert Opinion on Biological Therapy
@en-gb
Expert Opinion on Biological Therapy
@es
Expert Opinion on Biological Therapy
@fi
Expert Opinion on Biological Therapy
@fr
Expert Opinion on Biological Therapy
@it
altLabel
Expert Opin. Biol. Ther.
@de
Expert Opin. Biol. Ther.
@en
Expert Opin. Biol. Ther.
@en-gb
Expert Opin. Biol. Ther.
@fr
prefLabel
Expert Opinion on Biological Therapy
@ast
Expert Opinion on Biological Therapy
@da
Expert Opinion on Biological Therapy
@de
Expert Opinion on Biological Therapy
@en
Expert Opinion on Biological Therapy
@en-ca
Expert Opinion on Biological Therapy
@en-gb
Expert Opinion on Biological Therapy
@es
Expert Opinion on Biological Therapy
@fi
Expert Opinion on Biological Therapy
@fr
Expert Opinion on Biological Therapy
@it
P243
P3181
P4616
P1055
P1058
P1144
2001243388
P1156
P1160
Expert Opin. Biol. Ther.
P123
P1277
P1476
Expert Opinion on Biological Therapy
@en
P236
P243
P3181
P407
P571
2001-01-01T00:00:00Z